Haemonetics Income from Continuous Operations 2010-2025 | HAE
Haemonetics income from continuous operations from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| Haemonetics Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025 | $168 |
| 2024 | $118 |
| 2023 | $115 |
| 2022 | $43 |
| 2021 | $79 |
| 2020 | $77 |
| 2019 | $55 |
| 2018 | $46 |
| 2017 | $-26 |
| 2016 | $-56 |
| 2015 | $17 |
| 2014 | $35 |
| 2013 | $39 |
| 2012 | $67 |
| 2011 | $80 |
| 2010 | $58 |
| 2009 | $59 |
| Haemonetics Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-06-30 | $34 |
| 2025-03-31 | $58 |
| 2024-12-31 | $37 |
| 2024-09-30 | $34 |
| 2024-06-30 | $38 |
| 2024-03-31 | $20 |
| 2023-12-31 | $31 |
| 2023-09-30 | $25 |
| 2023-06-30 | $41 |
| 2023-03-31 | $29 |
| 2022-12-31 | $33 |
| 2022-09-30 | $33 |
| 2022-06-30 | $20 |
| 2022-03-31 | $10 |
| 2021-12-31 | $23 |
| 2021-09-30 | $15 |
| 2021-06-30 | $-4 |
| 2021-03-31 | $-11 |
| 2020-12-31 | $32 |
| 2020-09-30 | $48 |
| 2020-06-30 | $11 |
| 2020-03-31 | $18 |
| 2019-12-31 | $30 |
| 2019-09-30 | $37 |
| 2019-06-30 | $-8 |
| 2019-03-31 | $21 |
| 2018-12-31 | $18 |
| 2018-09-30 | $19 |
| 2018-06-30 | $-3 |
| 2018-03-31 | $12 |
| 2017-12-31 | $-7 |
| 2017-09-30 | $20 |
| 2017-06-30 | $20 |
| 2017-03-31 | $-51 |
| 2016-12-31 | $15 |
| 2016-09-30 | $20 |
| 2016-06-30 | $-10 |
| 2016-03-31 | $-9 |
| 2015-12-31 | $-59 |
| 2015-09-30 | $13 |
| 2015-06-30 | $0 |
| 2015-03-31 | $-3 |
| 2014-12-31 | $16 |
| 2014-09-30 | $7 |
| 2014-06-30 | $-4 |
| 2014-03-31 | $10 |
| 2013-12-31 | $16 |
| 2013-09-30 | $17 |
| 2013-06-30 | $-8 |
| 2013-03-31 | $13 |
| 2012-12-31 | $10 |
| 2012-09-30 | $7 |
| 2012-06-30 | $10 |
| 2012-03-31 | $18 |
| 2011-12-31 | $18 |
| 2011-09-30 | $14 |
| 2011-06-30 | $17 |
| 2011-03-31 | $21 |
| 2010-12-31 | $20 |
| 2010-09-30 | $21 |
| 2010-06-30 | $18 |
| 2010-03-31 | $4 |
| 2009-12-31 | $18 |
| 2009-09-30 | $18 |
| 2009-06-30 | $18 |
| 2009-03-31 | $14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.601B | $1.361B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.709B | 27.40 |
| Boston Scientific (BSX) | United States | $152.828B | 36.44 |
| Stryker (SYK) | United States | $144.352B | 29.38 |
| EssilorLuxottica (ESLOY) | France | $136.813B | 0.00 |
| Medtronic (MDT) | Ireland | $119.054B | 16.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.435B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.853B | 24.46 |
| ResMed (RMD) | United States | $41.628B | 29.73 |
| GE HealthCare Technologies (GEHC) | United States | $32.872B | 15.45 |
| Agilent Technologies (A) | United States | $32.560B | 21.23 |
| Terumo (TRUMY) | Japan | $27.538B | 32.63 |
| Koninklijke Philips (PHG) | Netherlands | $25.845B | 17.10 |
| Insulet (PODD) | United States | $21.612B | 72.43 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.663B | 12.52 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.829B | 0.00 |
| Baxter (BAX) | United States | $12.168B | 9.40 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.599B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.150B | 26.26 |
| Lantheus Holdings (LNTH) | United States | $3.889B | 10.52 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.364B | 23.53 |
| Prestige Consumer Healthcare (PBH) | United States | $3.227B | 14.32 |
| Perrigo (PRGO) | Ireland | $3.102B | 7.75 |
| ICU Medical (ICUI) | United States | $2.786B | 18.97 |
| LeMaitre Vascular (LMAT) | United States | $2.089B | 44.80 |
| AtriCure (ATRC) | United States | $1.755B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.624B | 10.22 |
| Green Thumb Industries (GTBIF) | United States | $1.509B | 64.82 |
| Curaleaf Holdings (CURLF) | Canada | $1.368B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.240B | 17.67 |
| Phibro Animal Health (PAHC) | United States | $1.139B | 14.56 |
| Acuren (TIC) | United States | $1.138B | 0.00 |
| Neogen (NEOG) | United States | $1.103B | 17.52 |
| BioLife Solutions (BLFS) | United States | $1.086B | 2268.00 |
| InMode (INMD) | Israel | $0.892B | 8.25 |
| Valneva SE (VALN) | France | $0.775B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.746B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.714B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.560B | 0.00 |
| Owens & Minor (OMI) | United States | $0.548B | 4.54 |
| ZimVie (ZIMV) | United States | $0.530B | 20.45 |
| Surmodics (SRDX) | United States | $0.506B | 0.00 |
| CeriBell (CBLL) | United States | $0.473B | 0.00 |
| SNDL (SNDL) | Canada | $0.441B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.414B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.393B | 13.54 |
| Evolus (EOLS) | United States | $0.382B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.367B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.347B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.341B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 20.88 |
| Canopy Growth (CGC) | Canada | $0.256B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.253B | 0.00 |
| Omeros (OMER) | United States | $0.251B | 0.00 |
| Cerus (CERS) | United States | $0.232B | 0.00 |
| Brainsway (BWAY) | Israel | $0.222B | 58.80 |
| Quanterix (QTRX) | United States | $0.221B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.220B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.214B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.203B | 0.00 |
| Exagen (XGN) | United States | $0.202B | 0.00 |
| Organigram Global (OGI) | Canada | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.06 |
| High Tide (HITI) | Canada | $0.176B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.170B | 0.00 |
| Biote (BTMD) | United States | $0.158B | 4.72 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| Safety Shot (SHOT) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Jin Medical (ZJYL) | China | $0.103B | 0.00 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.33 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Veru (VERU) | United States | $0.055B | 0.00 |
| Zynex (ZYXI) | United States | $0.044B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 32.50 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.11 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.017B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |